Skip to content

A rare hormone-resistance syndrome showed patterns across genetic groups

A case-based review linked different genetic patterns with age at presentation, blood pressure, potassium and hormone measurements, while leaving individual prognosis uncertain.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Among people reported with this rare syndrome, those with variants affecting both gene copies presented earlier and more often had high blood pressure or low potassium than heterozygotes. Hormone measurements also differed. These case-based associations help describe the disorder's range, but they do not predict an individual patient's course or establish treatment choices.

Keep in mind

The review combines published cases with hospital cases rather than following a defined population. Its blood-pressure and potassium association has a wide confidence interval, and the abstract does not provide follow-up duration.

Mapping a rare syndrome

Researchers combined published reports with additional hospital cases to examine clinical features, hormone tests and genetic variants. The question was how these characteristics relate within glucocorticoid resistance syndrome, rather than whether a treatment works.

Relationships do not establish treatment effects

The review found links between clinical features and hormone measurements, including higher cortisol. Such links describe how features occurred together in the reported cases; they do not show that changing a hormone level would improve symptoms.

CHECK THE ORIGINAL

The original publication

Glucocorticoid Resistance Syndrome: A Systematic Review of the Genotypes, Phenotypes, and Their Relationships.

Wang S, Su W, Duan L et al.
Endocr Pract · 2026

PubMed ID
41038576
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.